mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |